Developing new vaccines to protect against influenza and COVID-19
Collaborative Influenza Vaccine Innovation Centers (CIVICs): Component A: Vaccine Center, SARS-CoV-2
This study is exploring new vaccines and ways to deliver them to help protect people from different types of flu and COVID-19, and it may involve patients in testing how well these vaccines work and how safe they are.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Icahn School of Medicine at Mount Sinai NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project ID | NIH-11042078 on NIH RePORTER |
What this research studies
This research focuses on creating and testing innovative vaccine candidates and delivery methods to provide strong and lasting immunity against various strains of influenza and SARS-CoV-2, the virus responsible for COVID-19. The approach includes conducting immunologic analyses to guide vaccine design, performing tests to evaluate how well these vaccines work in both laboratory and clinical settings, and developing necessary assays and reagents. Patients may be involved in clinical trials to assess the effectiveness and safety of these new vaccines.
Who could benefit from this research
Good fit: Ideal candidates for participation include individuals at risk for influenza and COVID-19, such as healthcare workers, the elderly, and those with underlying health conditions.
Not a fit: Patients who are not at risk for influenza or COVID-19, or those who have already received effective vaccines, may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective vaccines that provide better protection against influenza and COVID-19.
How similar studies have performed: Previous research has shown promise in developing effective vaccines for influenza and COVID-19, indicating that this approach has potential for success.
Where this research is happening
New York, United States
- Icahn School of Medicine at Mount Sinai — New York, United States (Active)
Researchers
- Principal investigator: Krammer, Florian — Icahn School of Medicine at Mount Sinai
- Study coordinator: Krammer, Florian
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.